Back to top

Kepler Capital Remains a Hold on Novonesis (0Q4U)

Kepler Capital analyst Patrick Roquas maintained a Hold rating on Novonesis on August 27 and set a price target of DKK415.00. The company’s shares ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Novozymes A/S (NVZMY)